LAG3 and melanoma: A variety of immunosuppressive soluble factors trended toward elevation at baseline in the blood of patients with ICI-refractory melanoma versus healthy controls (Fig. 3A, Supplementary Data 1)29, including sCTLA-4, sLAG3, and sTIM-3.